CD2, Human (Siplizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD2, Human (Siplizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD2, Human (Siplizumab biosimilar)
CloneSiplizumab
Host SpeciesRecombinant Rat
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IP, FCM, FuncS, Neut, IF, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD2 Recombinant Antibody. Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
Immunogenn/a
Other NamesAnti-CD2 Recombinant Antibody, Research Grade Siplizumab, Anti-Human CD2 Recombinant Antibody, MEDI-507, Antibody Drug Analogues, Monoclonal Antibody, YR1030, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 288392-69-8
Catalog #YR1030
Priceplease inquire
Order / More InfoCD2, Human (Siplizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.